Jeremy M T J Dennison

5PUBLICATIONS
15CO-AUTHORS
Host-parasite interactionsNaturopathyObstetrics and gynaecologyPharmacogenomicsEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 07, 2026
Subgroup Analysis of Pooled Phase 3 Efficacy Data from Two Randomized Trials of Gepotidacin Versus Nitrofurantoin in Uncomplicated Urinary Tract Infections (EAGLE-2 and EAGLE-3) including Participants with Uropathogens Not-Susceptible to Nitrofurantoin.

|Jan 07, 2026
Early Symptom Response in Patients With Uncomplicated Urinary Tract Infection Treated With Gepotidacin or Nitrofurantoin: Pooled Analysis From Two Pivotal Phase 3 Studies.

Amanda J Sheets, Jeremy Dennison, Jason M Pogue

|Sep 09, 2025
Efficacy and in vitro activity of gepotidacin against bacterial uropathogens, including drug-resistant phenotypes, in females with uncomplicated urinary tract infections: results from two global, pivotal, phase 3 trials (EAGLE-2 and EAGLE-3).

Nicole E Scangarella-Oman, Deborah L Butler, John Breton

|Oct 22, 2021
Endogenous dopamine release in the human brain as a pharmacodynamic biomarker: evaluation of the new GPR139 agonist TAK-041 with [11C]PHNO PET.

Eugenii A Rabiner, Tolga Uz, Ayla Mansur

|Mar 24, 2021
Safety, tolerability and pharmacokinetics of emodepside, a potential novel treatment for onchocerciasis (river blindness), in healthy male subjects.

Jean-Yves Gillon, Jeremy Dennison, Frans van den Berg

Pageof 1

Frequent Collaborators

2 joint publications

Nicole E Scangarella-Oman

2 joint publications

Caroline Perry

1 joint publications

Jean-Yves Gillon

1 joint publications

Frans van den Berg